“CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary

February 18, 2020 “CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary

The futuristic facility will focus on process innovation and the production of designer biologics

Rentschler Biopharma's facility near Boston in Milford, MA combines our pioneering CDMO services with cutting edge technologies to provide innovative solutions for clinical and commercial manufacturing.

Moreover, this next generation 'smart' facility, will focus on process development, while leveraging real-time data analyses and built for purpose design solutions for designer biologics.

Ralf Otto, PhD, COO of Rentschler Biopharma SE and president and CEO of Rentschler Biopharma, Inc. shares details of the latest developments and future plans in building the site into a "CDMO and an innovation center."

To find out more about the facility expected to be in operation by the end of 2021, read the entire interview on the Website of Genetic Engineering & Biotechnology News.

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com